Susceptibility of Enterococcus faecalis to twelve antibiotics, time-kill assays, and high-level aminoglycoside resistance in a university hospital in Argentina
- PMID: 1815269
Susceptibility of Enterococcus faecalis to twelve antibiotics, time-kill assays, and high-level aminoglycoside resistance in a university hospital in Argentina
Abstract
A total of 201 Enterococcus faecalis strains isolated from different body sites were tested to (i) establish their antibiotic susceptibility pattern; (ii) determine the percentage of strains highly resistant (MIC greater than 2,000 micrograms/ml) to five aminoglycosides and (iii) know if the combination of penicillin or ampicillin plus an aminoglycoside is reliably synergistic for the strains with low-level resistance (MICs ranged from the break point of susceptibility for each aminoglycoside to 2,000 micrograms/ml). Erythromycin exhibited very poor activity with MIC90 greater than 128 micrograms/ml. Pefloxacin and norfloxacin had intermediate activity, inhibiting 50% of isolates at 4 micrograms/ml and 90% at 8 micrograms/ml. Trimethoprim-sulfamethoxazole (1:20) inhibited 94% of isolates at less than or equal to 2 micrograms/ml and 87.6% at less than or equal to 0.5 microgram/ml. Ampicillin, penicillin and piperacillin were the most potent agents studied. Ninety percent of strains were inhibited at 1 microgram/ml of ampicillin and 4 micrograms/ml of penicillin and piperacillin. The E. faecalis isolates were relatively or totally resistant to the aminoglycosides. Ninety six (47.8%) were highly resistant at least to one of them. High level resistance to streptomycin was found in 47.3% of all strains and was the most frequent resistance encountered; amikacin highly resistant strains were the less common and accounted for 4.5%. Low-level resistance to the aminoglycosides ranged from 50.2% (for streptomycin) to 94.5% (for amikacin). Thirty one E. faecalis isolates were selected for 24-time kill-assays. There was a good correlation between resistance to penicillin or ampicillin aminoglycoside synergy in all but 3 strains which were highly resistant. Among the strains with low-level resistance to the aminoglycosides, there was no synergy in 37 (63.8%) of 58 killing assays with each of the aminoglycosides combined with penicillin. These results demonstrate that the susceptibility to 2,000 micrograms/ml of the aminoglycoside does not assure the penicillin or ampicillin aminoglycoside synergism.
Similar articles
-
Enterococci and aminoglycosides: evaluation of susceptibility and synergism of their combination with piperacillin.Chemioterapia. 1987 Feb;6(1):12-6. Chemioterapia. 1987. PMID: 3103929
-
Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy.J Antimicrob Chemother. 2005 Nov;56(5):827-35. doi: 10.1093/jac/dki347. Epub 2005 Sep 26. J Antimicrob Chemother. 2005. PMID: 16186168
-
[Drug resistance of 100 clinical strains of Enterococcus spp].Med Dosw Mikrobiol. 1999;51(3-4):239-47. Med Dosw Mikrobiol. 1999. PMID: 10803253 Polish.
-
Antibiotic use in neonatal sepsis.Turk J Pediatr. 1998 Jan-Mar;40(1):17-33. Turk J Pediatr. 1998. PMID: 9722468 Review.
-
High-level aminoglycoside resistance in enterococci.Ann Biol Clin (Paris). 1992;50(10-11):671-4. Ann Biol Clin (Paris). 1992. PMID: 1306949 Review.
Cited by
-
Five-Year Antimicrobial Susceptibility Trends Among Bacterial Isolates from a Tertiary Health-Care Facility in Kigali, Rwanda.Am J Trop Med Hyg. 2016 Dec 7;95(6):1277-1283. doi: 10.4269/ajtmh.16-0392. Epub 2016 Oct 31. Am J Trop Med Hyg. 2016. PMID: 27799637 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical